Cardima's Pathfinder catheters approved in Japan
This article was originally published in Clinica
Executive Summary
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Cardima's Pathfinder diagnostic mapping catheters. The devices are designed to access and map the vasculature of the heart to locate the source of arrhythmias, facilitating their treatment. The catheters will be imported into Japan by medical device distributor Robert Reid, which has an exclusive distribution agreement with Cardima. They will be marketed there by Japan Lifeline, a sub-distributor of Robert Reid. Pathfinder catheters have been approved in the US since 1997, and are also available in Europe, Canada and Thailand.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.